Septin protein complex (Septin complex (commonly abbreviated as “septin complex”; individual septins like SEPT2, SEPT7 are abbreviated accordingly))

The septin protein complex is a cytoskeletal protein assembly composed of highly conserved, GTP-binding proteins (called septins), which polymerize as hetero-oligomeric rods to form filaments, rings, and cage-like structures at specific cellular locations[1][3][5][7][9]. Septin filament formation provides both structural scaffolds—recruiting proteins for coordinated cellular functions—and diffusion barriers that compartmentalize plasma membranes and organelles, playing pivotal roles in cytokinesis, cell polarity, neuronal morphogenesis, and immune defense[1][5][8]. Septins modulate essential processes such as vesicle trafficking, ciliogenesis, axon and dendrite branching, and pathogen restriction, and interact dynamically with actin and microtubule cytoskeletons[1][2][4][7][8]. Disruption or mutation of septin complexes has been implicated in various human pathological conditions, including cancers, neurodegenerative diseases, and infectious disease susceptibility[5][8]. While no drugs directly target septin complexes in clinical practice as of 2024, the system’s unique structural and regulatory characteristics offer emerging avenues for drug discovery and biomarker development[5]. If more specificity is needed (e.g., for individual septin isoforms like SEPT7), further context should be provided; “septin protein complex” refers to the multi-protein, heteromeric complexes fundamental to septin function across eukaryotic cells[1][3][5].

Other names

Septin complexSeptin filamentSeptin cytoskeletonHetero-oligomeric septin complex

Proposed mechanisms for targeting septins include disrupting septin filament assembly, modulating scaffold activity, altering diffusion barrier function, or destabilizing septin-protein interactions[5][8]. In infections, enhancing septin cage formation around bacteria may aid in bacterial autophagy[5].